Long-term use of Fosamax sustains or continues increases in bone density.
Rollins
Gina
G
D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D019386:Alendronate